Scientists launch major study to track rare immune diseases
NCT ID NCT00128973
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 9 times
Summary
This study is observing up to 3,500 people with immune system problems, including rare genetic conditions like chronic granulomatous disease and severe combined immunodeficiency. Researchers will track how these diseases change over time through blood tests, imaging, and checkups. The goal is to better understand these conditions and prepare for future treatment trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help researchers develop better treatments for rare immune disorders by understanding how these diseases progress.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly benefit participants and is focused on gathering data rather than testing a new therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC GRANULOMATOUS DISEASE (CGD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New hope for transplant patients: immune cell therapy targets stubborn graft-versus-host disease
- Gene fix trial aims to tame rare immune disease
- New study probes immune system in rare disease patients
- Double transplant breakthrough offers hope for rare immune disorder patients
- Gene-Editing breakthrough aims to fix immune cells in rare disease